Proterro
Proterro is a private biotech company that licenses a patented cyanobacteria-based platform to convert waste CO2 into customized sugars and nutritional products for partners in the food, feed, and energy industries.
- Company typePrivate
- Founded2008
- HeadquartersEwing, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Proterro does
Proterro is a private biotechnology company founded in 2008 and headquartered in Ewing, United States, that develops a patented two-step technology platform for converting waste CO2 into high-value sugars and nutritional products using genetically modified cyanobacteria. The platform operates in two stages: first, cyanobacteria are modified to produce molecules designed to a partner's specifications; second, those organisms are cultivated at high yield in a proprietary solid state bioreactor that enables cleaner harvesting and flexible back-end integration. The system is modular and can be deployed indoors, in open fields, or in greenhouses, allowing it to scale with partner growth and co-locate with industrial CO2 sources. Proterro has secured two granted patents covering the Two-Step Technology Platform and the Fully Integrated Production System.
The company commercializes exclusively through licensing agreements with industry partners rather than selling finished products directly. Its stated target customers are market leaders across three verticals — Food, Animal Feed, and Energy — with two branded product categories (Proterro Sugars and Proterro Nutritionals) developed under bespoke specifications and purity standards. Proterro has raised a single disclosed round of $3.5M in December 2012 led by Braemar Energy Ventures, with co-investors Battelle Ventures, Cultivian Ventures, Innovation Valley Partners, and Middleland Capital. Leadership consists of Founder and Co-CEO Kef Kasdin (also a board member) and Chief Business Development Officer David Austgen, supported by a team of 51-100 employees.
The company positions its value proposition around price stability, reliable supply, and customizable molecule design in industries traditionally dependent on crop-derived sucrose and feed inputs, with the environmental benefit of waste CO2 utilization as a secondary narrative. However, the available evidence — including a last-updated web footprint from 2019 and the absence of any disclosed customers, partnerships, or subsequent funding — indicates that commercial traction has not been publicly validated, making the company difficult to benchmark against operating peers.
Proterro firmographics
Firmographics- Name
- Proterro
- Legal name
- Proterro
- Website
- https://proterro.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Proterro is a private biotech company that licenses a patented cyanobacteria-based platform to convert waste CO2 into customized sugars and nutritional products for partners in the food, feed, and energy industries.
- Ownership category
- akta.pro rank
Proterro industry classification
Industry- Product category
- Industrial Biotechnology
- NAICS
- Other Basic Organic Chemical Manufacturing (32519), Sugar Manufacturing (31131)
- SIC
- Sugar & Confectionery Products (2060)
- akta.pro primary industry
- Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol) (EUAAAIAA)
Keywords
Where Proterro is headquartered
LocationHeadquarters
- HQ city
- Ewing
- HQ country
- United States
- HQ region
- North America
Markets served
Proterro business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain
Revenue model
- Licensing Agreements: Proterro generates revenue through license agreements with partners in the Food, Feed, and Energy industries. Partners pay for access to the company's patented technology platform and intellectual property to develop customized products.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Proterro product offering
Product offeringCore offering
Proterro operates a patented two-step biotechnology platform that uses genetically modified cyanobacteria to convert waste CO2 into high-value products. The company produces sugars and nutritionals in a unique solid state bioreactor system and delivers these capabilities to industrial partners in the food, animal feed, and energy industries under licensing agreements.
Product overview
Proterro is a biotechnology company offering a patented two-step technology platform that converts waste CO2 into high-value products using modified cyanobacteria. The platform includes two primary product categories: Proterro Sugars and Proterro Nutritionals. Products are developed under license agreements with partners in the global food, feed, and energy industries. The production process involves modifying cyanobacteria to produce molecules to partner specifications, then efficiently producing high-yield organisms in a unique solid state bioreactor system.
Differentiator
Problem solved
Functional benefit
Products and services
- Proterro Sugars
Quantifiable outcome
- Reduced environmental impact through waste CO2 utilization
- +3 more outcomes
Companies that use Proterro
Customer profileSegments5 records
Ideal customer profiles3 records
Proterro technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Proterro partnerships and signals
Strategic signalScale indicators2 records
Recent moves4 records
Expansion highlights2 records
Proterro competitors and assessment
Company assessmentDirect peers
- Joule Unlimited (Arctus): Cyanobacteria-based fuels and chemicals company (successor to Joule Unlimited). Directly comparable to Proterro on organism choice (cyanobacteria), target molecules (sugars/hydrocarbons for fuel and feed), and the well-documented challenges of cyanobacterial scale-up.
- LanzaTech: Gas fermentation company using engineered microbes to convert waste CO/CO2 into fuels and chemicals, licensing its technology to industrial partners. Highly comparable to Proterro in waste-gas-to-product biology, licensing GTM, and energy/fuel end-markets.
- Solazyme / TerVia (Corbion): Algae-based oils and ingredients company, now part of Corbion's TerVia algae ingredients platform. Comparable to Proterro in using photosynthetic microorganisms to produce food/feed ingredients and in the licensing/partnering commercialization model.
- Amyris: Synthetic biology company engineering microorganisms to produce bio-based ingredients (sugars, oils, specialty chemicals) under a licensing and partnership model. Most directly comparable to Proterro as a microbe-to-product biotech with multi-vertical end-market reach in food, feed, and personal care.
Broad incumbents
- Roquette: Global starch, polyol, and bio-based ingredient manufacturer serving food, feed, and pharma. Comparable to Proterro as a large incumbent in the sugar/starch-derived ingredients space Proterro aims to disrupt.
- SunOpta: Plant-based and specialty ingredient company serving food and beverage with non-GMO, organic, and plant-based ingredients. Comparable to Proterro in addressing food and feed customers seeking sustainable, non-commodity ingredient alternatives.
- Tate & Lyle: Global food ingredients company specializing in sweeteners, texturants, and sucralose. Comparable to Proterro as a major incumbent in industrial sweetener and food ingredient markets.
Emerging players
- Algenol: Cyanobacteria-based fuel and chemical production company. Comparable to Proterro in organism platform, CO2-to-product biology, and the commercial challenges of scaling cyanobacterial production.
- Synthetic Genomics: Synthetic biology and algae-based production company developing microbe-derived fuels, nutritionals, and aquaculture feeds. Comparable to Proterro in platform biology and the food/feed/energy application stack.
- Bota Bio: Synthetic biology company engineering microbial strains for food, feed, personal care, and pharma ingredients. Comparable to Proterro as a microbe-based B2B ingredients platform targeting similar end markets.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Proterro social profiles
Digital presenceProterro financial estimates
Financial estimateRevenue estimate
Valuation estimate
Proterro leadership team
Management profileNumber of profiles
Profiles2 records
Proterro funding detail
Funding detailFunding overview
Funding rounds1 record
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Proterro M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Proterro
What does Proterro do?
Proterro operates a patented two-step biotechnology platform that uses genetically modified cyanobacteria to convert waste CO2 into high-value products. The company produces sugars and nutritionals in a unique solid state bioreactor system and delivers these capabilities to industrial partners in the food, animal feed, and energy industries under licensing agreements.
Is Proterro a public or private company?
Proterro is a private company. It is classified as venture growth investor backed and is currently operating.
When was Proterro founded?
Proterro was founded in 2008. It employs 51 to 100 people.
Where is Proterro based?
Proterro is headquartered in Ewing, United States, in the North America region.
How does Proterro make money?
One revenue line is on record: licensing Agreements.
Who are Proterro's main competitors?
Direct peers on record are Joule Unlimited (Arctus), LanzaTech, Solazyme / TerVia (Corbion) and Amyris. Broad incumbents are Roquette, SunOpta and Tate & Lyle. Emerging players are Algenol, Synthetic Genomics and Bota Bio.
Does Proterro have an API?
No public API is recorded for Proterro.
What industry is Proterro in?
Proterro's product category is Industrial Biotechnology. Its primary akta.pro industry code is EUAAAIAA, Bio-based Platform & Commodity Chemicals (e.g., bio-ethylene, bio-propylene, bio-BTX, bio-methanol). Its NAICS code is 32519 and its SIC code is 2060.